AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 5

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 98.66 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019012VilonASYASY-{CAT}-1626Janoshik2025-Q399.938.26—Buyer-sourced0FAIL
AX-2025-018708AOD-9604QSCQSC-2508-B7258Janoshik2025-Q399.703.9391.1Buyer-sourced0PASS
AX-2025-018646MK-677 (Ibutamoren mesylate)QSCQSC-2507-F5673Kestrel2025-Q399.654.78—Buyer-sourced1FAIL
AX-2025-021092PemvidutideBCHBCH-2506-G4536Janoshik2025-Q397.975.58—Supplier-supplied0PASS
AX-2025-020953LiraglutideWXTWXT-2504-L3444Janoshik2025-Q397.455.96—Supplier-supplied0FAIL
AX-2025-020666TirzepatideSGNSGN-2506-J8349Medutest2025-Q397.891.82—Buyer-sourced0PASS
AX-2025-020662TirzepatideSGNSGN-2506-J8349Janoshik2025-Q397.412.3596.9Buyer-sourced0PASS
AX-2025-020604BPC-157SSASSA-2505-J7334PeptideMeter2025-Q398.363.46—Buyer-sourced1MARGINAL
AX-2025-020144MOTS-cERPERP-2508-M9453Janoshik2025-Q399.682.87—Supplier-supplied0PASS
AX-2025-020119SemaglutideERPERP-2508-S8293Janoshik2025-Q399.383.11103.7Laboratory-retained2FAIL
AX-2025-0201055-Amino-1MQSWBSWB-2507-E8786VendorInvestigate2025-Q398.765.9699.4Buyer-sourced1FAIL
AX-2025-018876SemaglutideTFSTFS-{CAT}-8947VendorInvestigate2025-Q398.185.75—Buyer-sourced0PASS
AX-2025-018869BPC-157TFSTFS-{CAT}-8964Janoshik2025-Q399.575.0294.5Buyer-sourced0PASS
AX-2025-018583SemaglutideQYBQYB-2505-U5049Nordanalyt2025-Q399.733.9290.7Laboratory-retained0PASS
AX-2025-020802SemaglutideCPCCPC-2504-G1688Janoshik2025-Q398.584.5198.4Buyer-sourced0PASS
AX-2025-020159IpamorelinERPERP-2502-S9437Medutest2025-Q399.674.2591.0Buyer-sourced0PASS
AX-2025-019473BPC-157JEEPJEEP-2506-R8215Nordanalyt2025-Q398.932.95101.5Buyer-sourced1FAIL
AX-2025-019466BPC-157JEEPJEEP-2504-X7849PeptideMeter2025-Q398.606.28105.5Buyer-sourced0PASS
AX-2025-018752Melanotan IIQSCQSC-2503-D7103Janoshik2025-Q399.886.20—Buyer-sourced0PASS
AX-2025-018724SS-31 (Elamipretide)QSCQSC-2502-M6829Medutest2025-Q397.925.1297.3Buyer-sourced1FAIL
AX-2025-020525SemaglutideSSASSA-2502-U6907Kestrel2025-Q398.105.1298.8Buyer-sourced0PASS
AX-2025-020239RetatrutideGGPepsGGPE-2508-E1731Medutest2025-Q397.932.1888.8Buyer-sourced1MARGINAL
AX-2025-020163CJC-1295 with DACERPERP-2506-E9178Janoshik2025-Q398.984.8293.8Buyer-sourced0PASS
AX-2025-019911PEG-MGFHJHJ-2507-S5943Janoshik2025-Q397.657.0791.8Buyer-sourced0PASS
AX-2025-019642RetatrutideTFCTFC-2508-L1799PeptideMeter2025-Q397.814.25—Laboratory-retained0PASS
AX-2025-019570TirzepatideTFCTFC-2507-T1116VendorInvestigate2025-Q398.033.5998.1Buyer-sourced0PASS
AX-2025-019568TirzepatideTFCTFC-2507-T1116Medutest2025-Q397.823.43—Buyer-sourced0PASS
AX-2025-019566TirzepatideTFCTFC-2507-T1116PeptideMeter2025-Q397.953.56—Buyer-sourced0PASS
AX-2025-019461BPC-157JEEPJEEP-2504-X7849Janoshik2025-Q398.747.14—Buyer-sourced0PASS
AX-2025-019265GHRP-6AMBAMB-2508-T5301Janoshik2025-Q399.436.07—Buyer-sourced0PASS
AX-2025-018873BPC-157TFSTFS-{CAT}-8964Janoshik2025-Q399.385.18101.4Buyer-sourced0PASS
AX-2025-018656MK-677 (Ibutamoren mesylate)QSCQSC-2507-F5673Janoshik2025-Q399.634.05101.2Buyer-sourced1FAIL
AX-2025-020893Enclomiphene citrateWXTWXT-2506-V2798Janoshik2025-Q398.914.31—Buyer-sourced0FAIL
AX-2025-020875BPC-157WXTWXT-2506-M1881Janoshik2025-Q399.163.5589.4Buyer-sourced1MARGINAL
AX-2025-020839KPVCPCCPC-2502-M2176Nordanalyt2025-Q398.142.79—Buyer-sourced0FAIL
AX-2025-020811TirzepatideCPCCPC-2502-E1731PeptideMeter2025-Q398.552.4095.4Buyer-sourced3MARGINAL
AX-2025-020721BPC-157SGNSGN-2507-F9360Janoshik2025-Q398.825.14—Buyer-sourced0PASS
AX-2025-020575TirzepatideSSASSA-2502-D7226VendorInvestigate2025-Q397.946.51—Buyer-sourced2FAIL
AX-2025-0203515-Amino-1MQMKMMKM-2508-K4002PeptideMeter2025-Q398.551.7890.2Buyer-sourced0FAIL
AX-2025-020145MOTS-cERPERP-2508-M9453Janoshik2025-Q398.721.66—Buyer-sourced0PASS